Приказ основних података о документу
The Effect of Topical Doxycycline on Corneal Neovascularization
dc.creator | Jovanović, Vesna | |
dc.creator | Nikolić, Ljubisa | |
dc.date.accessioned | 2020-07-02T12:53:58Z | |
dc.date.available | 2020-07-02T12:53:58Z | |
dc.date.issued | 2014 | |
dc.identifier.issn | 0271-3683 | |
dc.identifier.uri | https://smile.stomf.bg.ac.rs/handle/123456789/1943 | |
dc.description.abstract | Purpose: To examine the effect of topical doxycycline on human corneal neovascularization (CONV). Materials and methods: Six eyes of six patients with CONV received topical 1% doxycycline four times per day for three weeks and monitored for a total of one year. Ophthalmic evaluations included visual acuity, tonometry, slit-lamp examination, conjunctival swabs, quantification of CONV and photography. Results: CONV either disappeared or was attenuated, shortened and less dense in five of six patients. There were no adverse effects. Conclusion: Topical doxycycline was effective in reducing CONV and healing of the ocular surface. | en |
dc.publisher | Taylor & Francis Inc, Philadelphia | |
dc.rights | restrictedAccess | |
dc.source | Current Eye Research | |
dc.subject | Cornea | en |
dc.subject | doxycycline | en |
dc.subject | neovascularization | en |
dc.title | The Effect of Topical Doxycycline on Corneal Neovascularization | en |
dc.type | article | |
dc.rights.license | ARR | |
dcterms.abstract | Јовановић, Весна; Николић, Љубиса; | |
dc.citation.volume | 39 | |
dc.citation.issue | 2 | |
dc.citation.spage | 142 | |
dc.citation.epage | 148 | |
dc.citation.other | 39(2): 142-148 | |
dc.citation.rank | M22 | |
dc.identifier.wos | 000330070500004 | |
dc.identifier.doi | 10.3109/02713683.2013.833246 | |
dc.identifier.pmid | 23964705 | |
dc.identifier.scopus | 2-s2.0-84893004728 | |
dc.type.version | publishedVersion |